NIH R01 · 2024
Hispanic Latino Lipid Consortium
ABSTRACT Cardiometabolic diseases (CMD), including obesity, dyslipidemia, type 2 diabetes, and hypertension, are the leading cause of disease burden in the world with a disproportionate impact on historically marginalized populations. In the first funding period of our project, The Hispanic/Latino Lipid Consortium (HLLC), our efforts centered on discovering genetic factors impacting serum lipid levels, obesity, and T2D in self-identified Hispanic/Latinos (HL), a population with significant CMD health disparities. This highly impactful research, which has resulted in 39 published papers to-date, leveraged extant genetic data as well as new genetic data generated for the project in >63k…
From the public funding record at NIH RePORTER. Describes the funded project, not the reviews below.